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Two recent papers, one in this issue of Immunity (Zhong et al., 2008), report the identification of a membrane
protein, termed MITA or STING, that activates the transcription factor IRF3 to induce type-I interferons to
mitigate viral infection.Viral invasion exposes viral nucleic acids,
which trigger the activation of the host
innate immune system (Pichlmair and
Reis e Sousa, 2007). In the case of RNA
viruses, the viral RNA is detected by
Toll-like receptors (TLRs) in the endo-
some or by retinoic acid-inducible gene-I
(RIG-I)-like receptors (RLRs) in the cyto-
sol. These receptors then initiate signaling
cascades culminating in the induction of
type-1 interferons (e.g., IFNa and IFNb;
collectively termed IFN-1) and other
immune effector molecules to limit viral
infection. Two new studies, one de-
scribed in this issue of Immunity, identify
a membrane protein that plays a key role
in linking RLRs to IFN-1 production
(Zhong et al., 2008; Ishikawa and Barber,
2008). Interestingly, this protein, termed
MITA or STING, is also important in
triggering IFN-1 induction by double-
stranded DNA in the cytosol.
The RLR family of receptors, consisting
of RIG-I, MDA5, and LGP2, are cytosolic
RNA helicases that bind to double-
stranded RNA. RIG-I also contains
a C-terminal regulatory domain that binds
to 50-triphosphorylated single-stranded
RNA, which is distinguished from the
host cytosolic RNA. The N termini of
RIG-I and MDA5, but not LGP2, contain
two tandem CARD domains that interact
with the CARD domain of mitochondrial
antiviral signaling protein (MAVS; also
known as VISA, IPS-1, or CARDIF) (Fig-
ure 1). MAVS then activates two cytosolic
protein kinase complexes, one consisting
of IKKa, IKKb, and NEMO and the other
containing TBK1 or IKK3 and various
adaptor proteins, including NEMO and
TANK. The IKK and TBK1 complexes
activate the transcription factors NF-kB
and IRFs (e.g., IRF3 and IRF7), respec-
tively, which assemble into an enhanceo-some complex to turn on the transcription
of IFNb. How MAVS activates the cyto-
solic kinases was not well understood.
Two groups performed overexpression
screens to identifyproteins that can induce
IRF3-dependent reporter genes, and both
identified a previously uncharacterized
gene that encodes a protein containing
four or five transmembrane domains
(Zhong et al., 2008; Ishikawa and Barber,
2008). This protein, termedMITA or STING
(hereafter referred to as MITA), potently
activates IRF3 and suppresses viral repli-
cation when it is overexpressed in cells.
Reducing the expression of this gene by
RNA interference (RNAi) inhibited IRF3
activation and exacerbated viral infection.
Ishikawa and Barber further deleted the
gene encoding MITA in mice and found
that embryonic fibroblasts lacking this
protein were compromised in their ability
to restrict RNA virus replication. Induction
of IFNb by Sendai virus was also inhibited,
albeit not completely, in the fibroblasts
lacking MITA. However, the removal of
MITA in bone-marrow-derived macro-
phagesanddendritic cells did not enhance
viral replication, suggesting that the
requirement of MITA in signaling by RNA
viruses may be specific to cell type. This
phenotype is distinct from that of RIG-I or
MAVS deficiency, which leads to a
complete blockade of IFNa and IFNb
induction in multiple cell types, including
fibroblasts, macrophages, and conven-
tional dendritic cells (Kumar et al., 2006;
Sun et al., 2006). Nevertheless, both
groups showed that MITA functions
downstream of RIG-I and MAVS and up-
stream of TBK1. Biochemical experiments
showed that MITA forms a complex with
MAVS, RIG-I, and TBK1, suggesting that
MITA functions as an adaptor that links
MAVS to TBK1 (Figure 1).Immunity 29Although both groups concluded that
MITA is an important signaling adaptor in
the RIG-I pathway, they came to a differ-
ent conclusion regarding the localization
and the mechanism of function of this
protein. Zhong et al. showed that MITA
is localized to the mitochondrial outer
membrane, where it interacts with MAVS
(Figure 1, left). These authors further
showed that MITA is phosphorylated by
TBK1 (predominantly at Ser-358) and
that this phosphorylation is important for
it to recruit TBK1 to the mitochondria,
thereby facilitating IRF3 phosphorylation
by TBK1. The mitochondrial localization
of MITA was independently discovered
by another recent report, which identified
MITA (also termed MPYS) as a protein
that is associated with major histocom-
patibility complex II (MHC-II) and required
for MHC-II-mediated cell death (Jin et al.,
2008). In contrast, Ishikawa et al. found
that MITA is a transmembrane protein on
the endoplasmic reticulum (ER), where it
associates with the TRAP complex, which
is known to facilitate protein translocation
across the ER by the Sec61 translocon
complex (Figure 1, right). The translocon
can associate with another protein com-
plex known as exocyst, which has been
reported to associate with TBK1 and
play a role in IFNb induction (Chien et al.,
2006). RNAi of components of each of
these complexes inhibits IFNb induction
by MITA, supporting a role for these
ER-associated proteins in the antiviral
immune response. Further work is clearly
needed to clarify the localization of MITA
and to investigate the mechanism of its
action. It is possible that MITA is distrib-
uted both in mitochondria and in the ER,
just as other mitochondrial proteins
can also be found in the ER (e.g., Bcl-2;
Kaufmann et al., 2003)., October 17, 2008 ª2008 Elsevier Inc. 513
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Viral double-stranded RNA or single-stranded RNA bearing 50-triphosphate is recognized by the RNA
helicase RIG-I in the cytosol. RIG-I then activates MAVS, which is localized on the mitochondrial outer
membrane. MAVS interacts with MITA in the mitochondrial membrane (left side), resulting in the recruit-
ment of TBK1 and IRF3 and thus facilitating the phosphorylation of IRF3 as well as MITA by TBK1. In
an alternative model (right side), MITA is localized on the membrane of the endoplasmic reticulum (ER),
where it interacts with the TRAP complex, which in turn associates with the Sec61 translocon complex
and the exocyst complex. These ER-associated protein complexes recruit TBK1 to phosphorylate
IRF3. MITA also leads to the activation of IKK and NF-kB, and the latter forms an enhanceosome complex
with IRF3 and other transcriptional activators to induce IFNb. The cytosolic DNA can also induce IFNb
through MITA, but the pathway that links DNA recognition to MITA remains largely unknown.There are other notable differences
between the two studies. For example,
whereas Zhong et al. found that overex-
pression of MITA activated IRF3 but not
NF-kB, Ishikawa and Barber showed
that MITA could activate both transcrip-
tion factors to induce IFNb. Zhong et al.514 Immunity 29, October 17, 2008 ª2008 Efound that RNAi of MITA impaired IFNb
induction by the double-stranded RNA
poly(I:C), which is known to signal through
MDA5 when it is transfected into cells. In
contrast, Ishikawa and Barber showed
that the loss of MITA did not prevent
IFN-1 induction by poly(I:C) or poliovirus,lsevier Inc.the latter also depending onMDA5 for sig-
naling. Consistent with this result, they
showed that MITA binds to RIG-I but not
MDA5. The observations that MITA binds
to RIG-I specifically and that MITA associ-
ates with the ER translocon complexes
led the authors to speculate that MITA
might assist in the recognition and signal-
ing of translating viral RNA by RIG-I.
Despite these differences, it is clear
from both studies that MITA is important
for immune responses against certain
RNA viruses. Interestingly, both groups
found that MITA plays a critical role in
IFNb induction by double-stranded
B-form DNA in the cytosol. When DNA is
introduced to thecytosol bybacterial or vi-
ral infection, or by pathological conditions
that ‘‘leak’’ the host DNA from the nucleus
or mitochondria, it triggers a potent IFN-1
production that can fight the microbial in-
fection but can also lead to autoimmune
diseases such as systemic lupus erythe-
matosus (Stetson and Medzhitov, 2006).
This cytosolic DNA signaling pathway is
independent of RIG-I, MDA5, or MAVS
but depends on TBK1 and IRF3. The sen-
sor and adaptor for the cytosolic DNA are
largely unknown. The new studies provide
convincing evidence that deficiency in
MITA leads to a severe defect in IFNb in-
duction by cytosolic DNA in multiple cell
types (Ishikawa and Barber, 2008). Fur-
thermore, the DNA virus herpes simplex
virus-1 (HSV-1) and the bacteria Listeria
monocytogenes, both of which are known
to deliver DNA to the host cytoplasm,
failed to trigger IFNb production in MITA-
deficient fibroblasts. These results raise
the exciting possibility that MITA is an
adaptor-like molecule that integrates
both DNA and RNA signaling pathways
in the cytosol.
The identification of MITA fills a gap in
the nucleic acid signaling pathways and
advances our understanding of antiviral
innate immunity. This discovery also
raises important questions that need to
be further addressed. Because the
MITA-deficient mice are viable and de-
velop normally, we should expect to
know soon whether MITA is indeed im-
portant for immune defense against vari-
ous viruses and bacteria in vivo. This is
especially important given that macro-
phages and dendritic cells lacking MITA
can restrict viral replication normally ex
vivo and that even fibroblasts are still
able to produce reduced, but substantial,
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Mechanistically, the intracellular localiza-
tion of MITA and the role of its membrane
localization should be clarified. The asso-
ciation of MITA with the ER translocon
complex is intriguing, but how the translo-
con complex plays a role in IFNb induction
remains to be elucidated. The biochemi-
cal mechanism by which MITA mediates
IFNb induction by cytosolic DNA is
another promising area of future explora-
tion, and this line of research may facili-
tate the discovery of a cytosolic DNA
sensor (or sensors).Inhibitory Recepto
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Natural killer cell inhibitory receptors
ylate molecules involved in activatio
inhibitory receptors also signal tyros
A defining feature of natural killer (NK)
cell recognition of cellular targets is the
presence of inhibitory receptors specific
for target cell MHC class I molecules
(Yokoyama, 2008). In mice, these recep-
tors are type II integral membrane
proteins with C-type lectin-like domains
(predominantly the Ly49 family of recep-
tors), whereas human NK cells utilize
primarily type I integralmembraneproteins
with immunoglobulin (Ig)-like domains,
termed killer Ig-like receptors (KIRs), in
an example of convergent evolution. In ad-
dition, NK cells from both species express
the lectin-like CD94-NKG2A inhibitory re-
ceptors for HLA-E and Qa-1. Regardless
of these striking differences in structure
and topology, both structural types of in-
hibitory receptors block effector functions
triggered by NK cell activation receptors.
In this issue, Peterson and Long describe
new insight into the mechanism of inhibi-
tory-receptor signaling (Peterson and
Long, 2008).
Upon ligand engagement, the immu-
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SHP-2, and the inositol phosphatase,
SHIP. Among these, the NK cell inhibitory
receptors preferentially recruit and
activate SHP-1, which is required for inhi-
bition. The consensus view has been that
the phosphatases then dephosphorylate
molecules in activation-receptor-signal-
ing cascades (Figure 1). Considerable
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target(s) of SHP-1 for determining
whether it directly dephosphorylates
many substrates or only specific targets
in the context of NK cell inhibitory-recep-
tor function. Addressing this issue is chal-
lenging because both possibilities could
result in global decreases in activation-
induced tyrosine phosphorylation, either
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directly or downstream of a specific target
that fails to transmit the activation signal.
To determinewhether SHP-1 has a spe-
cific target in human NK cells, the Long
laboratory previously employed an NK
cell line expressing defined KIRs and
exposed it to targets expressing HLA
ligands for the KIR of interest, rather
than antibody crosslinking (Stebbins et al.,
2003). Furthermore, they utilized a ‘‘trap-
ping’’ mutant of SHP-1 that had amutation
in the critical catalytic residue yet was
still able to bind and trap substrate. The
SHP-1 mutant was fused to the cytoplas-
mic domain of a KIR, allowing identifica-
tion of SHP-1 substrates that specifically
resulted from KIR interactions with cog-
nate ligand HLA. Vav1 was thus identified
as a specific target of SHP-1 in human NK
cells (Figure 1); those observations were
extended in the current paper to another
human NK cell line (Peterson and Long,
2008).
Vav1 belongs to a family of guanine
nucleotide exchange factors for the Rho
family of GTPases, and Vav proteins play
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